Morgan Stanley »

Alnylam Pharmaceuticals shares owned by Morgan Stanley

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2023-09-30 $214M 1.2M 177.10
2023-06-30 $357M 1.9M 189.94
2022-12-31 $331M 1.4M 237.65
2022-06-30 $161M 1.1M 142.86
2022-03-31 $140M 849k 164.52
2021-06-30 $320M 1.9M 169.81
2020-12-31 $0 1.7M 0.00
2020-09-30 $222M 1.5M 145.99
2020-06-30 $224M 1.5M 148.10
2020-03-31 $151M 1.4M 108.87
2019-12-31 $178M 1.5M 115.17
2019-09-30 $110M 1.4M 80.42
2019-03-31 $119M 1.2M 97.56
2018-12-31 $86M 1.2M 72.91
2018-09-30 $108M 1.2M 87.51
2018-06-30 $124M 1.3M 98.48
2018-03-31 $150M 1.3M 119.13
2017-12-31 $149M 1.2M 127.06
2017-03-31 $36M 702k 51.25
2016-12-31 $30M 812k 37.45
2016-09-30 $57M 840k 67.80
2016-06-30 $49M 875k 55.46
2016-03-31 $68M 1.1M 62.75
2015-12-31 $103M 1.1M 94.08
2015-09-30 $97M 1.2M 80.33
2015-06-30 $156M 1.3M 119.84
2014-12-31 $134M 1.4M 97.07
2014-09-30 $67M 862k 78.10
2014-06-30 $55M 868k 63.20
2014-03-31 $50M 739k 67.20
2013-12-31 $48M 742k 64.31
2013-09-30 $12M 191k 63.99